{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:12Z","timestamp":1792787832735,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"the Shanghai Science and Technology Committee (STCSM)","award":["15140903200"],"award-info":[{"award-number":["15140903200"]}]},{"name":"the Shanghai Science and Technology Committee (STCSM)","award":["16411953500"],"award-info":[{"award-number":["16411953500"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81572836"],"award-info":[{"award-number":["81572836"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3671-0","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T14:40:48Z","timestamp":1508769648000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Whether intermediate-risk stage 1A, grade 1\/2, endometrioid endometrial cancer patients with lesions larger than 2\u00a0cm warrant lymph node dissection?"],"prefix":"10.1186","volume":"17","author":[{"given":"Menghan","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,23]]},"reference":[{"key":"3671_CR1","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1525-1438.1997.00005.x","volume":"7","author":"T Leijon","year":"1997","unstructured":"Leijon T, Rosenberg P, Boeryd B. Total abdominal hysterectomy and bilateral salpingo-oophorectomy: a sufficient treatment for patients with low risk endometrial carcinoma. Int J Gynecol Cancer. 1997;7:376\u201380.","journal-title":"Int J Gynecol Cancer"},{"key":"3671_CR2","first-page":"1343","volume-title":"Berek's & Novak's gynecology. 14th ed: Lipincott Williams & Wilkins","author":"JR Lurain","year":"2007","unstructured":"Lurain JR. Uterine cancer. In: Berek JS, editor. Berek's & Novak's gynecology. 14th ed: Lipincott Williams & Wilkins; 2007. p. 1343\u2013401."},{"key":"3671_CR3","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/IGC.0000000000000120","volume":"24","author":"PJ Coronado","year":"2014","unstructured":"Coronado PJ, Fasero M, Baquedano L, Martinez-Maestre MA, Casado A, Vidart JA, et al. Impact of the lymphadenectomy in high-risk histologic types of endometrial cancer: a matched-pair study. Int J Gynecol Cancer. 2014;24:703\u201312.","journal-title":"Int J Gynecol Cancer"},{"key":"3671_CR4","doi-asserted-by":"publisher","unstructured":"May K, Bryant A, Dickinson HO, Kehoe S, Morrison J. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev. 2010:CD007585. \nhttps:\/\/doi.org\/10.1002\/14651858.CD007585.pub2.","DOI":"10.1002\/14651858.CD007585.pub2."},{"key":"3671_CR5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1525-1438.2007.00996.x","volume":"18","author":"DS Chi","year":"2008","unstructured":"Chi DS, Barakat RR, Palayekar MJ, Levine DA, Sonoda Y, Alektiar K, et al. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer. 2008;18:269\u201373.","journal-title":"Int J Gynecol Cancer"},{"key":"3671_CR6","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/01.AOG.0000245444.14015.00","volume":"108","author":"AS Case","year":"2006","unstructured":"Case AS, Rocconi RP, Straughn JM, Conner M, Novak L, Wang WQ, et al. A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer. Obstet Gynecol. 2006;108:1375\u20139.","journal-title":"Obstet Gynecol"},{"key":"3671_CR7","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","volume":"100","author":"PB Panici","year":"2008","unstructured":"Panici PB, Basile S, Maneschi F, Lissoni AA, Signorelli M, Scambia G, et al. Systematic pelvic lymphadenectomy vs no nymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100:1707\u201316.","journal-title":"J Natl Cancer Inst"},{"key":"3671_CR8","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","volume":"355","author":"CL Creutzberg","year":"2000","unstructured":"Creutzberg CL, van Putten W, Koper P, Lybeert M, Jobsen JJ, Warlam-Rodenhuis CC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. Lancet. 2000;355:1404\u201311.","journal-title":"Lancet"},{"issue":"Suppl 8","key":"3671_CR9","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","volume":"60","author":"WT Creasman","year":"1987","unstructured":"Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study. Cancer. 1987;60(Suppl 8):2035\u201341.","journal-title":"Cancer"},{"key":"3671_CR10","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1067\/mob.2000.107335","volume":"182","author":"A Mariani","year":"2000","unstructured":"Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol. 2000;182:1506\u201316.","journal-title":"Am J Obstet Gynecol"},{"key":"3671_CR11","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(09)62002-X","volume":"375","author":"Y Todo","year":"2010","unstructured":"Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet. 2010;375:1165\u201372.","journal-title":"Lancet"},{"issue":"Suppl 6","key":"3671_CR12","doi-asserted-by":"publisher","first-page":"vi33","DOI":"10.1093\/annonc\/mdt353","volume":"24","author":"N Colombo","year":"2013","unstructured":"Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, et al. Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi33\u20138. \nhttps:\/\/doi.org\/10.1093\/annonc\/mdt353\n\n.","journal-title":"Ann Oncol"},{"key":"3671_CR13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ygyno.2013.10.023","volume":"132","author":"KM Doll","year":"2014","unstructured":"Doll KM, Tseng J, Denslow SA, Fader AN, Gehrig PA. High-grade endometrial cancer: revisiting the impact of tumor size and location on outcomes. Gynecol Oncol. 2014;132:44\u20139.","journal-title":"Gynecol Oncol"},{"key":"3671_CR14","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/IGC.0b013e318269f68e","volume":"22","author":"CY Zhang","year":"2012","unstructured":"Zhang CY, Wang C, Feng WW. Clinicopathological risk factors for pelvic lymph node metastasis in clinical early-stage endometrioid endometrial adenocarcinoma. Int J Gynecol Cancer. 2012;22:1373\u20137.","journal-title":"Int J Gynecol Cancer"},{"key":"3671_CR15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/IGC.0000000000000609","volume":"26","author":"N Colombo","year":"2016","unstructured":"Colombo N, Creutzberg C, Amant F, Bosse T, Gonzalez-Martin A, Ledermann J, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer diagnosis, treatment and follow-up. Int J Gynecol Cancer. 2016;26:2\u201330.","journal-title":"Int J Gynecol Cancer"},{"issue":"Suppl 2","key":"3671_CR16","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/j.ijgo.2015.06.005","volume":"131","author":"F Amant","year":"2015","unstructured":"Amant F, Mirza MR, Koskas M, Creutzberg CL. Cancer of the corpus uteri. Int J Gynaecol Obstet. 2015;131(Suppl 2):S96\u2013104.","journal-title":"Int J Gynaecol Obstet"},{"key":"3671_CR17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/AOG.0b013e318240de51","volume":"119","author":"MR Milam","year":"2012","unstructured":"Milam MR, Java J, Walker JL, Metzinger DS, Parker LP, Coleman RL. Nodal metastasis risk in endometrioid endometrial cancer. Obstet Gynecol. 2012;119:286\u201392.","journal-title":"Obstet Gynecol"},{"key":"3671_CR18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ygyno.2012.06.035","volume":"127","author":"SC Dowdy","year":"2012","unstructured":"Dowdy SC, Borah BJ, Bakkum-Gamez JN, Weaver AL, McGree ME, Haas LR, et al. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol. 2012;127:5\u201310.","journal-title":"Gynecol Oncol"},{"key":"3671_CR19","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1097\/IGC.0000000000000490","volume":"25","author":"R Dos Reis","year":"2015","unstructured":"Dos Reis R, Burzawa JK, Tsunoda AT, Hosaka M, Frumovitz M, Westin SN, et al. Lymphovascular space invasion portends poor prognosis in low-risk endometrial cancer. Int J Gynecol Cancer. 2015;25:1292\u20139.","journal-title":"Int J Gynecol Cancer"},{"key":"3671_CR20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ygyno.2012.10.009","volume":"128","author":"MM AlHilli","year":"2013","unstructured":"AlHilli MM, Podratz KC, Dowdy SC, Bakkum-Gamez JN, Weaver AL, McGree ME, et al. Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Gynecol Oncol. 2013;128:294\u20139.","journal-title":"Gynecol Oncol"},{"key":"3671_CR21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1245\/s10434-015-4583-3","volume":"23","author":"G Canlorbe","year":"2016","unstructured":"Canlorbe G, Bendifallah S, Laas E, Raimond E, Graesslin O, Hudry D, et al. Tumor size, an additional prognostic factor to include in low-risk endometrial cancer: results of a French multicenter study. Ann Surg Oncol. 2016;23:171\u20137.","journal-title":"Ann Surg Oncol"},{"key":"3671_CR22","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ejogrb.2011.04.031","volume":"158","author":"T Turan","year":"2011","unstructured":"Turan T, Hizli D, Sarici S, Boran N, Gundogdu B, Karadag B, et al. Is it possible to predict para-aortic lymph node metastasis in endometrial cancer? Eur J Obstet Gynecol Reprod Biol. 2011;158:274\u20139.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"Suppl 3","key":"3671_CR23","doi-asserted-by":"crossref","first-page":"S936","DOI":"10.1245\/s10434-015-4798-3","volume":"22","author":"Y Borghesi","year":"2015","unstructured":"Borghesi Y, Narducci F, Bresson L, Tresch E, Meurant JP, Cousin S, et al. Managing endometrial cancer: the role of pelvic lymphadenectomy and secondary surgery. Ann Surg Oncol. 2015;22(Suppl 3):S936\u201343.","journal-title":"Ann Surg Oncol"},{"key":"3671_CR24","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1097\/PAS.0b013e318299f2ab","volume":"37","author":"E Euscher","year":"2013","unstructured":"Euscher E, Fox P, Bassett R, Al-Ghawi H, Ali-Fehmi R, Barbuto D, et al. The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma. Am J Surg Pathol. 2013;37:1728\u201336.","journal-title":"Am J Surg Pathol"},{"key":"3671_CR25","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ygyno.2004.11.033","volume":"96","author":"JM Briet","year":"2005","unstructured":"Briet JM, Hollema H, Reesink N, Aalders JG, Mourits M, Ten Hoor KA, et al. Lymphvascular space involvement: an independent prognostic factor in endometrial cancer. Gynecol Oncol. 2005;96:799\u2013804.","journal-title":"Gynecol Oncol"},{"key":"3671_CR26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/his.12254","volume":"64","author":"GM Han","year":"2014","unstructured":"Han GM, Lim D, Leitao MM, Abu-Rustum NR, Soslow RA. Histological features associated with occult lymph node metastasis in FIGO clinical stage I, grade I endometrioid carcinoma. Histopathology. 2014;64:389\u201398.","journal-title":"Histopathology"},{"key":"3671_CR27","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1006\/gyno.1997.4788","volume":"66","author":"JG Bell","year":"1997","unstructured":"Bell JG, Minnick A, Reid GC, Judis J, Brownell M. Relationship of nonstaging pathological risk factors to lymph node metastasis and recurrence in clinical stage I endometrial carcinoma. Gynecol Oncol. 1997;66:388\u201392.","journal-title":"Gynecol Oncol"},{"key":"3671_CR28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/PGP.0b013e318285657b","volume":"33","author":"JD Hertel","year":"2014","unstructured":"Hertel JD, Huettner PC, Pfeifer JD. Lymphovascular space invasion in microcystic elongated and fragmented (MELF)-pattern well-differentiated endometrioid adenocarcinoma is associated with a higher rate of lymph node metastasis. Int J Gynecol Pathol. 2014;33:127\u201334.","journal-title":"Int J Gynecol Pathol"},{"key":"3671_CR29","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1365-2559.2011.03802.x","volume":"58","author":"K Pavlakis","year":"2011","unstructured":"Pavlakis K, Messini I, Vrekoussis T, Panoskaltsis T, Chrysanthakis D, Yiannou P, et al. MELF invasion in endometrial cancer as a risk factor for lymph node metastasis. Histopathology. 2011;58:966\u201373.","journal-title":"Histopathology"},{"key":"3671_CR30","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1080\/00313020903041135","volume":"41","author":"C Stewart","year":"2009","unstructured":"Stewart C, Brennan BA, Leung YC, Little L. MELF pattern invasion in endometrial carcinoma: association with low grade, myoinvasive endometrioid tumours, focal mucinous differentiation and vascular invasion. Pathology. 2009;41:454\u20139.","journal-title":"Pathology"},{"key":"3671_CR31","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0002-9378(85)90371-0","volume":"151","author":"PJ DiSaia","year":"1985","unstructured":"DiSaia PJ, Creasman WT, Boronow RC, Blessing JA. Risk factors and recurrent patterns in stage I endometrial cancer. Am J Obstet Gynecol. 1985;151:1009\u201315.","journal-title":"Am J Obstet Gynecol"},{"key":"3671_CR32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","volume":"40","author":"CP Morrow","year":"1991","unstructured":"Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a gynecologic oncology group study. Gynecol Oncol. 1991;40:55\u201365.","journal-title":"Gynecol Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3671-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T14:40:57Z","timestamp":1508769657000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3671-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,23]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3671"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3671-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,23]]},"article-number":"696"}}